Menopause

Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025

SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing…

3 months ago

Welltory Secures $2 Million Credit Line from Braavo Capital to Accelerate AI Health Companion Launch and Global Expansion

NEW YORK, Nov. 5, 2025 /PRNewswire/ -- Welltory, the consumer health platform turning wearable data into personalized daily guidance, has…

3 months ago

OMRON Healthcare Wins Best in Class in the 2025 Digital Health Awards at HLTH

Expert judges determining the best of the best in healthcare innovation recognized OMRON Healthcare for its blood pressure monitors with…

3 months ago

Beauty-Stem’s “Beauty Beyond Age” Forum

Regenerative Medicine Brings New Confidence and Grace to Women in Menopause ARCADIA, CALIFORNIA / ACCESS Newswire / October 28, 2025…

3 months ago

FSA Store® Shares 4 Steps to Avoid Forfeiting Flexible Spending Account (FSA) Funds to the December 31 Use-It-Or-Lose-It Deadline

Consumers forfeit an estimated $3 billion each year because they fail to spend their FSA contributions by December 31; FSA…

3 months ago

Weekly Recap: 12 Tech Press Releases You Need to See

A roundup of the most newsworthy tech announcements from PR Newswire this week, including the release of VERA-MH by Spring Health…

3 months ago

Carrot Launches Carrot Rx ‘Flex Program’ For U.S Employers to Access Even More Cost Savings for Employees

Employers can now implement fertility pharmacy benefits with even more customization, maximizing access to price transparency and cost savings  WEST…

3 months ago

The Menopause Society Receives $5 Million Grant from the Steven & Alexandra Cohen Foundation to Forward the Digital-Innovation Phase of Its NextGen Now Initiative

Grant will help create a robust digital ecosystem designed to transform and scale menopause education and training worldwide CLEVELAND, Oct.…

3 months ago

Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women

Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women 10…

3 months ago

Elektra Health and Oscar Launch HelloMeno the First-Ever Menopause Health Plan in the Individual Market

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Elektra Health ("Elektra"), a top virtual menopause care provider, and Oscar Health, Inc. ("Oscar")…

3 months ago